The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of axitinib intensification compared to nivolumab alone after induction with ipilimumab plus nivolumab in patients with mRCC without previous complete response (AxIn study).
 
Chiara Ciccarese
No Relationships to Disclose
 
Elena Verzoni
Consulting or Advisory Role - Janssen Oncology; MSD/AstraZeneca; Pfizer
Speakers' Bureau - Ipsen; Janssen Oncology; MSD Oncology; Novartis
 
Davide Bimbatti
Consulting or Advisory Role - Ipsen; MSD
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; MSD
 
Sebastiano Buti
Consulting or Advisory Role - BMS; BMS; Ipsen; Merck/Pfizer; MSD; Pfizer; Pfizer
Speakers' Bureau - BMS; Ipsen; Merck/Pfizer; MSD; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Fabio Calabrò
No Relationships to Disclose
 
Luca Galli
Expert Testimony - Bristol-Myers Squibb/Celgene; Janssen Oncology; MSD; Pfizer; Pfizer
 
Sarah Scagliarini
No Relationships to Disclose
 
Giuseppe Fornarini
No Relationships to Disclose
 
Cinzia Baldessari
No Relationships to Disclose
 
Domenico Bilancia
No Relationships to Disclose
 
Gaetano Facchini
No Relationships to Disclose
 
Carlo Cattrini
Consulting or Advisory Role - AstraZeneca; Janssen; MSD
Research Funding - Gilead Sciences
Travel, Accommodations, Expenses - Bayer; BMS; Ipsen; Janssen; MSD
 
Cristina Masini
No Relationships to Disclose
 
Maria Olga Giganti
No Relationships to Disclose
 
Giuseppa Scandurra
No Relationships to Disclose
 
Franco Nole
No Relationships to Disclose
 
Alfredo Berruti
No Relationships to Disclose
 
Michele Milella
Honoraria - AstraZeneca; Ipsen; Janssen Oncology; MSD; Roche
Consulting or Advisory Role - Novartis
Research Funding - Roche (Inst)
 
Lorenzo Antonuzzo
No Relationships to Disclose
 
Roberto Iacovelli
Honoraria - Astellas Pharma; IPSEN; MSD; Pfizer
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; Bayer; Eisai; Janssen; Merck; MSD; Novartis; Pfizer; Sanofi
Speakers' Bureau - Ipsen; Janssen; MSD; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; MSD; Pfizer